AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33602580 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone recruitment manoeuvres
Number of subjects: 30
Study 33602580 — intervention group
Group type: COMPARATOR
Intervention: Supine recruitment manoeuvres
Number of subjects: 30
Study 616667359 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention promoting adequate and healthy eating for 9 months
Number of subjects: 0
Study 616667359 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 32053254 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Well Multicultural‐Lifestyle Management Program (LWM‐LMP)
Number of subjects: 0
Study 32164612 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS delivery of TB test results
Number of subjects: 10
Study 32484752 — intervention group
Group type: EXPERIMENTAL
Intervention: SES-RP/NP (modified Sexual Experiences Survey-Short Form Victimization)
Number of subjects: 442
Study 32484752 — intervention group
Group type: COMPARATOR
Intervention: SES-SFV (traditional Sexual Experiences Survey-Short Form Victimization)
Number of subjects: 442
Study 32484752 — intervention group
Group type: COMPARATOR
Intervention: SVAWS (Severity of Violence Against Women Scales)
Number of subjects: 442
Study 32933561 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 75
Study 32933561 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 75
Study 32933561 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching and toning exercises
Number of subjects: 75
Study 32933561 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 75
Study 35830179 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity tracker and fortnightly health-coaching sessions for 3 months
Number of subjects: 51
Study 32189364 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine treatment
Number of subjects: 0
Study 32189364 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon therapy after lamivudine resistance
Number of subjects: 0
Study 35577281 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging program with brief in-person education and 3 months of educational text messages
Number of subjects: 221
Study 35577281 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging program
Number of subjects: 221
Study 35577281 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 221
Study 33340805 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial distraction (attending phone calls with questions inducing visuospatial processing)
Number of subjects: 0
Study 33340805 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual distraction (attending phone calls with questions requiring semantic memory)
Number of subjects: 0
Study 33340805 — intervention group
Group type: COMPARATOR
Intervention: No-distraction
Number of subjects: 0
Study 33712919 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate
Number of subjects: 2000
Study 33712919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study 35139272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty
Number of subjects: 1225
Study 35139272 — intervention group
Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty
Number of subjects: 1225
Study 33946085 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostemsavir 600 mg twice daily with optimized background therapy (OBT)
Number of subjects: 107
Study 32989898 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-related factors (role conflict, effort, utilization of job skills, reward, social support)
Number of subjects: 807
Study 32750261 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-IPV-Hib-HepB vaccine
Number of subjects: 160
Study 32750261 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine (PENTACEL™ or INFANRIX™ hexa)
Number of subjects: 160
Study 36068618 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive family-based lifestyle modification programme
Number of subjects: 3682
Study 36068618 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3682
Study 34454654 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 338
Study 34454654 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 338
Study 32321350 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 inspired oxygen
Number of subjects: 25
Study 32321350 — intervention group
Group type: COMPARATOR
Intervention: 0.21 inspired oxygen
Number of subjects: 25
Study 36029653 — intervention group
Group type: EXPERIMENTAL
Intervention: FP/bevacizumab + atezolizumab (800 mg 60-min i.v. infusion q2 weeks)
Number of subjects: 445
Study 36029653 — intervention group
Group type: COMPARATOR
Intervention: Control (fluoropyrimidine (FP)/bevacizumab)
Number of subjects: 445
Study 36029653 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental (FP/bevacizumab + atezolizumab)
Number of subjects: 445
Study 32861217 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 84 mg nasal spray twice weekly for 4 weeks with standard of care
Number of subjects: 230
Study 32861217 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray twice weekly for 4 weeks with standard of care
Number of subjects: 230
Study 34784076 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS)
Number of subjects: 50
Study 34784076 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance cholangiopancreatography (MRCP)
Number of subjects: 50
Study 34784076 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS) after negative MRCP
Number of subjects: 50
Study 34784076 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance cholangiopancreatography (MRCP) after negative EUS
Number of subjects: 50
Study 34784076 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EUS and MRCP
Number of subjects: 50
Study 33856570 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily subcutaneous teriparatide (TPD) 20 mcg
Number of subjects: 26
Study 33856570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic teriparatide (TPD) followed by raloxifene (RLX) 60 mg
Number of subjects: 26
Study 35509490 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 0
Study 35509490 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 0
Study 36343657 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental manipulation promoting more malleable emotion beliefs
Number of subjects: 0
Study 36343657 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 33647946 — intervention group
Group type: EXPERIMENTAL
Intervention: CLIP score (based on cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide)
Number of subjects: 458
Study 33647946 — intervention group
Group type: EXPERIMENTAL
Intervention: CLIP score
Number of subjects: 458
Study 32719420 — intervention group
Group type: EXPERIMENTAL
Intervention: End-effector robot-assisted gait training (E-RAGT)
Number of subjects: 28
Study 32719420 — intervention group
Group type: COMPARATOR
Intervention: Bodyweight-supported treadmill training (BWST)
Number of subjects: 28
Study 35278336 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM) grafting
Number of subjects: 20
Study 35278336 — intervention group
Group type: COMPARATOR
Intervention: Control (implant surgery alone)
Number of subjects: 20
Study 35077296 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-48h
Number of subjects: 10
Study 35077296 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-24h
Number of subjects: 10
Study 35077296 — intervention group
Group type: COMPARATOR
Intervention: Control (no RT)
Number of subjects: 10
Study 35157537 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCR programme 'Cogmed' with continuous support from a health professional
Number of subjects: 72
Study 35157537 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCR programme 'Brain+ Health' with continuous support from a health professional
Number of subjects: 72
Study 35157537 — intervention group
Group type: COMPARATOR
Intervention: Active-control training with continuous support from a health professional
Number of subjects: 72
Study 35157537 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCR programme 'Brain+ Health' without support
Number of subjects: 72
Study 34072293 — intervention group
Group type: EXPERIMENTAL
Intervention: Krill oil (2.3 g omega-3 daily)
Number of subjects: 555
Study 34072293 — intervention group
Group type: COMPARATOR
Intervention: Control (macadamia nut oil)
Number of subjects: 555
Study 35243421 — intervention group
Group type: COMPARATOR
Intervention: Topically applied lactobacilli, daily application for 8 weeks.
Number of subjects: 0
Study 35243421 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 0
Study 36176927 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Chinese herbal fumigation sitz-bath and red ointment
Number of subjects: 118
Study 36176927 — intervention group
Group type: COMPARATOR
Intervention: Red ointment therapy
Number of subjects: 118
Study 32678132 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 3 months
Number of subjects: 55
Study 32678132 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL) group
Number of subjects: 55
Study 35289545 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaxial system with permanent infiltration anesthesia
Number of subjects: 296
Study 35289545 — intervention group
Group type: COMPARATOR
Intervention: Conventional CT-guided transthoracic trepanobiopsy
Number of subjects: 296
Study 34170932 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c ADA definition (5.7%-6.4%)
Number of subjects: 1378
Study 34170932 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c WHO-IEC definition (6.0%-6.4%)
Number of subjects: 1378
Study 34170932 — intervention group
Group type: EXPERIMENTAL
Intervention: FPG ADA definition (5.6-6.9 mmol/l)
Number of subjects: 1378
Study 34170932 — intervention group
Group type: EXPERIMENTAL
Intervention: FPG ADA pre-diabetes criterion
Number of subjects: 1378
Study 32481390 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic intersphincteric resection
Number of subjects: 159
Study 32481390 — intervention group
Group type: COMPARATOR
Intervention: Extralevator abdominoperineal resection (L-ELAPE)
Number of subjects: 159
Study 35405973 — intervention group
Group type: EXPERIMENTAL
Intervention: 2800 IU of vitamin D3/day for 8 weeks
Number of subjects: 200
Study 35405973 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 200
Study 33932133 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 0
Study 35850110 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise (moderate- and vigorous-intensity levels)
Number of subjects: 36
Study 35850110 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise (moderate- and vigorous-intensity levels)
Number of subjects: 36
Study 35710473 — intervention group
Group type: EXPERIMENTAL
Intervention: Erroneous example elaboration training
Number of subjects: 91
Study 35710473 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 91
Study 33246428 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine with bevacizumab and radiotherapy (arm A)
Number of subjects: 0
Study 33246428 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine and radiotherapy without bevacizumab (arm B)
Number of subjects: 0
Study 36348422 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth-based exercise for 6 months
Number of subjects: 80
Study 36348422 — intervention group
Group type: COMPARATOR
Intervention: Usual follow-up care for the first 3 months, then mHealth-based exercise for the next 3 months
Number of subjects: 80
Study 33772702 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 188
Study 33772702 — intervention group
Group type: COMPARATOR
Intervention: Control (no workshop)
Number of subjects: 188
Study 33772702 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Regulation (SR)
Number of subjects: 188
Study 32548619 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublobar resection (wedge resection or segmentectomy)
Number of subjects: 430
Study 32548619 — intervention group
Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 430
Study 35728369 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuspan regimen of magnesium sulfate (MgSO4) for 24 hours
Number of subjects: 33
Study 35728369 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibai regimen of magnesium sulfate (MgSO4) for 24 hours
Number of subjects: 33
Study 33112259 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 1156
Study 33112259 — intervention group
Group type: EXPERIMENTAL
Intervention: Turner syndrome (45,X)
Number of subjects: 1156
Study 33112259 — intervention group
Group type: EXPERIMENTAL
Intervention: Turner syndrome women with a 45,X/46,XX karyotype
Number of subjects: 1156
Study 33112259 — intervention group
Group type: EXPERIMENTAL
Intervention: Turner syndrome (general)
Number of subjects: 1156
Study 35908008 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic ergometer program for 2 weeks
Number of subjects: 15
Study 35908008 — intervention group
Group type: COMPARATOR
Intervention: Seated flexibility exercise in addition to usual care
Number of subjects: 15
Study 35908008 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic ergometer program
Number of subjects: 15
Study 35908008 — intervention group
Group type: COMPARATOR
Intervention: Seated flexibility exercise
Number of subjects: 15
Study 34228836 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 30 mg/kg q12h
Number of subjects: 26
Study 34228836 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 30 mg/kg q8h
Number of subjects: 26
Study 34228836 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 60 mg/kg q8h
Number of subjects: 26
Study 34228836 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 90 mg/kg q12h
Number of subjects: 26
Study 34228836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 32075695 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention (TMI) adjunct to standard care (30-min group-based smoking cessation counseling and nicotine patches)
Number of subjects: 80
Study 32075695 — intervention group
Group type: COMPARATOR
Intervention: Standard care (30-min group-based smoking cessation counseling and nicotine patches)
Number of subjects: 80
Study 36302567 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg plus standard therapy
Number of subjects: 257
Study 36302567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study 32014846 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based intervention using Swedish Military training app (FMTK), Acupedo walking app, and LogMyFood food photography app.
Number of subjects: 110
Study 32014846 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise and health coaching intervention including 1 weekly supervised exercise session.
Number of subjects: 110
Study 32014846 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based intervention
Number of subjects: 110
Study 32014846 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise intervention
Number of subjects: 110
Study 33032451 — intervention group
Group type: EXPERIMENTAL
Intervention: High rapport condition
Number of subjects: 114
Study 33032451 — intervention group
Group type: COMPARATOR
Intervention: Low rapport condition
Number of subjects: 114
Study 33248014 — intervention group
Group type: EXPERIMENTAL
Intervention: rONB
Number of subjects: 82
Study 33248014 — intervention group
Group type: COMPARATOR
Intervention: sONB
Number of subjects: 82
Study 35022952 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium oxide (500 mg)
Number of subjects: 64
Study 35022952 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (500 mg)
Number of subjects: 64
Study 33809392 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo training program (90 min, three times a week, for 12 weeks)
Number of subjects: 20
Study 33809392 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo training program
Number of subjects: 20
Study 33809392 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 32039721 — intervention group
Group type: EXPERIMENTAL
Intervention: Group antenatal care
Number of subjects: 6
Study 32039721 — intervention group
Group type: COMPARATOR
Intervention: Individual antenatal care
Number of subjects: 6
Study 36047381 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowering Community Pharmacists program (monthly resources/reminders + educational webinar)
Number of subjects: 55
Study 36047381 — intervention group
Group type: COMPARATOR
Intervention: Control group (monthly reminders only)
Number of subjects: 55
Study 33413291 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/GLY/MF 150/50/80 μg (ICS medium-dose)
Number of subjects: 33
Study 33413291 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/GLY/MF 150/50/160 μg (ICS high-dose)
Number of subjects: 33
Study 33413291 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/GLY/MF (both doses)
Number of subjects: 33
Study 32256907 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.33% ropivacaine (Group QLB)
Number of subjects: 88
Study 32256907 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group Con)
Number of subjects: 88
Study 36408966 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 60
Study 36408966 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 60
Study 35837868 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 150
Study 35837868 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 150
Study 35837868 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature
Number of subjects: 150
Study 35837868 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics+Clinical nomogram
Number of subjects: 150
Study 32938869 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional mechanical plaque removal (PMPR) with removal of the superstructure
Number of subjects: 20
Study 32938869 — intervention group
Group type: COMPARATOR
Intervention: Professional mechanical plaque removal (PMPR) without removal of the superstructure
Number of subjects: 20
Study 33857466 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 60
Study 33857466 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 60
Study 32106885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention package consisting of structured sessions of behavior activation, problem-solving treatment, and parenting skills training delivered by primary maternal health care providers and supported by a 'neighborhood mother'.
Number of subjects: 0
Study 32106885 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control group).
Number of subjects: 0
Study 32106885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention package.
Number of subjects: 0
Study 32852138 — intervention group
Group type: EXPERIMENTAL
Intervention: LooH with a spiritual component (Spiritist passe Group - SPG)
Number of subjects: 120
Study 32852138 — intervention group
Group type: EXPERIMENTAL
Intervention: LooH without a spiritual component (LooH Group - LHG)
Number of subjects: 120
Study 32852138 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 120
Study 32933470 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided great auricular nerve block (GANB) with 2 ml of 0.25% ropivacaine
Number of subjects: 60
Study 34385093 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed Aloe Vera Gel (PAG)
Number of subjects: 100
Study 34385093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32804414 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesized dynamic treatment regimes (DTRs)
Number of subjects: 2
Study 32804414 — intervention group
Group type: COMPARATOR
Intervention: Alternative methods
Number of subjects: 2
Study 36001752 — intervention group
Group type: EXPERIMENTAL
Intervention: CNI (Calcineurin Inhibitors)
Number of subjects: 830
Study 36001752 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus
Number of subjects: 830
Study 32102184 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary acid load (measured by PRAL score)
Number of subjects: 3081
Study 32102184 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary acid load (measured by NEAP score)
Number of subjects: 3081
Study 32102184 — intervention group
Group type: COMPARATOR
Intervention: HbA1c levels <5.6%
Number of subjects: 3081
Study 36191758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cordella PAP Sensor
Number of subjects: 0
Study 33706698 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60
Study 33706698 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study 32360128 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 120
Study 32360128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet
Number of subjects: 120
Study 32360128 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 35905418 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional transarterial chemoembolization (cTACE)
Number of subjects: 486
Study 35905418 — intervention group
Group type: EXPERIMENTAL
Intervention: SMAART score
Number of subjects: 486
Study 35905418 — intervention group
Group type: COMPARATOR
Intervention: ART score
Number of subjects: 486
Study 34331112 — intervention group
Group type: COMPARATOR
Intervention: Without CAD
Number of subjects: 200
Study 34331112 — intervention group
Group type: EXPERIMENTAL
Intervention: With CAD
Number of subjects: 200
Study 32240761 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 2342
Study 32240761 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 2342
Study 34520295 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverage (target peak BrAC = .10%)
Number of subjects: 299
Study 34520295 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage
Number of subjects: 299